Emma Tallantyre

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 364 citations · Full text

Medicine, Internal Medicine, Neurology +14

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions

Emma Tallantyre, Jennifer Dixon, Ian Donaldson et al. · Neurology · 2011 · 217 citations · Full text

Medicine, Neurology, Radiology +17

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

Emma Tallantyre, Lars Bø, Omar Alrawashdeh et al. · Multiple Sclerosis Journal · 2010 · 174 citations

Life Sciences, Neurology, Neuroscience +15

A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS Lesions

Emma Tallantyre, Paul S. Morgan, Jennifer Dixon et al. · Investigative Radiology · 2009 · 163 citations

Medicine, Neurology, Radiology +17